ADALTA
AdAlta Pty Ltd (AdAlta) is a Melbourne based biotech company discovering and developing protein based therapeutics. AdAlta aims to provide an alternative approach to drug discovery by finding novel shark antibody or i-body drug candidate agents for various disease conditions. AdAlta has significant expertise and proprietary libraries that will enable the discovery and identification of lead candidates. AdAlta can rapidly identify high quality binders from it's i-body or shark antibody libra... ries. A particular focus is given to the discovery of protein therapeutics against non-traditional antibody targets, such as complex membrane spanning proteins. AdAltaโs proprietary discovery technology is particularly well suited to approach this class of drug-targets that formerly was inaccessible to most protein-binder platforms. AdAlta is focused on building a pipeline of therapeutics against clinically validated targets that demonstrate significant advantages over currently marketed protein products. AdAlta also conducts collaborative and contract research. Our approach allows us to leverage the diversity of the AdAlta libraries and apply it to collaborators targets. AdAlta has a number of collaborations with research organization, biotech and pharma companies.
ADALTA
Industry:
Biotechnology Health Care Wellness
Founded:
2010-01-01
Address:
Bundoora, Victoria, Australia
Country:
Australia
Website Url:
http://www.adalta.com.au
Total Employee:
101+
Status:
Active
Contact:
+61394795159
Email Addresses:
[email protected]
Total Funding:
3 M AUD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta WordPress Google Analytics Google Maps Content Delivery Network Font Awesome Global Site Tag HSTS Google Universal Analytics
Similar Organizations
Allos Therapeutics
Allos Therapeutics is a biopharmaceutical company that develops and commercializes anti-cancer therapeutics.
Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Orteq
Orteq is a medical device company that develops and commercializes bioengineering solutions for orthopaedic injuries.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Yuuwa Capital
Yuuwa Capital investment in Series A - AdAlta
Brisbane Angels
Brisbane Angels investment in Series A - AdAlta
Official Site Inspections
http://www.adalta.com.au
- Host name: sau-e9713-or.servercontrol.com.au
- IP address: 118.127.60.243
- Location: Doncaster Australia
- Latitude: -37.7855
- Longitude: 145.1202
- Timezone: Australia/Melbourne
- Postal: 3108
More informations about "AdAlta"
Developing i-body drugs to treat fibrotic diseases - AdAlta
Based in Melbourne, AdAlta is led by an experienced management team and Board and is supported by a world class scientific advisory board. Home; About Us. AdAlta at a glance; โฆSee details»
AdAlta at a glance - AdAlta - Developing i-body drugs to treat โฆ
AdAlta commenced a human Phase 1 clinical trial for AD-214 in July 2020. AdAlta is continuing further discovery and development of the i-body platform, directed towards other disease โฆSee details»
AdAlta Ltd - The Org
AdAlta (ASX:1AD) is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human โฆSee details»
AdAlta - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +61394795159; AdAlta Pty Ltd (AdAlta) is a Melbourne based biotech company discovering and developing protein based therapeutics. AdAlta aims to provide an alternative โฆSee details»
AdAlta - Business News
AdAlta Ltd (1AD) is an Australian-based drug development company headquartered in Melbourne. The Company is using its proprietary technology platform to generate a promising new class of โฆSee details»
CTPL to be AdAltaโs preferred manufacturer of immunotherapies
May 12, 2024 AdAlta and SYNBV have identified an opportunity to rapidly expand AdAltaโs clinical stage pipeline in the field of cellular immunotherapy. AdAlta and SYNBV are working โฆSee details»
AdAlta - Overview, News & Similar companies | ZoomInfo.com
Who is AdAlta. AdAlta Ltd is a clinical stage drug development company headquartered in Melbourne, Australia. Using its proprietary i-body technology platform, Ad Alta aims to solve โฆSee details»
Management Team - AdAlta - Developing i-body drugs to treat โฆ
AdAltaโs management team has been responsible for the development of the i-body technology platform, including the identification and pre-clinical development of the lead i-body drug โฆSee details»
AdAlta - businessabc.net
Dec 9, 2024 AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, โฆSee details»
AdAlta Limited - MTPConnect
AdAlta Limited is developing pre-clinical and clinical imaging tools for the cell surface receptor CXCR4 in idiopathic pulmonary fibrosis (IPF) patients. IPF is a progressive, degenerative lung โฆSee details»
AdAlta Limited (ASX: 1AD) Company Profile & Overview - Stock โฆ
Oct 25, 2024 AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD โฆSee details»
Adalta Limited - Company Profile Report | IBISWorld
Jun 30, 2021 Adalta Limited is an ASX listed clinical stage biotechnology company. The company is engaged in the following biotechnological projects: i-bodies โ This antibody is โฆSee details»
ASX:1AD - AD-214 clinical advisory board
Back to . AdAlta. AD-214 clinical advisory board. Released 09 Oct 24. Q&As Share. Follow. Latest announcements. Open panel View summary and Q&As. Announcement summary. AD-214 โฆSee details»
CORPORATE FACT SHEET - AdAlta
AdAlta Limited 15/2 Park Drive, Bundoora 3083 Victoria, Melbourne Australia Email: [email protected] Website: www.adalta.com.au Key financial details ASX code 1AD โฆSee details»
ASX:1AD - Annual Report to shareholders
Back to . AdAlta. Annual Report to shareholders. Released 28 Aug 24. Q&As Share. Follow. Latest announcements. Open panel View summary and Q&As. Ask a question. Your question โฆSee details»
AdAlta Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 28, 2024 AdAlta has 5 employees across 2 locations and $1.74 m in annual revenue in FY 2024. See insights on AdAlta including office locations, competitors, revenue, financials, โฆSee details»
Board - AdAlta - Developing i-body drugs to treat fibrotic diseases
Paul MacLeman CHAIRMAN. Paul has over 25 yearsโ experience across all phases of the life sciences sector. With a career-spanning veterinary practice, pharmaceutical development and โฆSee details»
Welcome to the AdAlta investor hub!
We welcome our shareholders and prospective shareholders to join the ASX:1AD investor hub and engage with the community.See details»
Corporate Governance - AdAlta - Developing i-body drugs to treat ...
The Board of Directors of AdAlta Limited is responsible for the corporate governance of the economic entity and guides and monitors the business and affairs of the Company on behalf of โฆSee details»